{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:51:56Z","timestamp":1791942716183,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T00:00:00Z","timestamp":1423785600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/1475-2891-14-14","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T03:51:33Z","timestamp":1434599493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus"],"prefix":"10.1186","volume":"14","author":[{"given":"Raynold V","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia J","family":"Phung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,13]]},"reference":[{"issue":"5","key":"880_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2174\/187152612804142215","volume":"12","author":"K Yeghiazaryan","year":"2012","unstructured":"Yeghiazaryan K, Schild HH, Golubnitschaja O: Chromium-picolinate therapy in diabetes care: individual outcomes require new guidelines and navigation by predictive diagnostics.Infect Disord Drug Targets 2012,12(5):332\u20139. 10.2174\/187152612804142215","journal-title":"Infect Disord Drug Targets"},{"key":"880_CR2","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","volume":"27","author":"S Wild","year":"2004","unstructured":"Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.Diabetes Care 2004, 27:1047\u201353. 10.2337\/diacare.27.5.1047","journal-title":"Diabetes Care"},{"key":"880_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1477-7525-9-83","volume":"9","author":"L Hakobyan","year":"2011","unstructured":"Hakobyan L, Haaijer-Ruskamp FM, de Zeeuw D, Dobre D, Denig P: A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients.Health Qual Life Outcomes 2011, 9:83. doi:10.1186\/1477\u20137525\u20139-83 10.1186\/1477-7525-9-83","journal-title":"Health Qual Life Outcomes"},{"issue":"10","key":"880_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2105\/AJPH.92.10.1648","volume":"92","author":"GY Yeh","year":"2002","unstructured":"Yeh GY, Eisenberg DM, Davis RB, Phillips RS: Use of complementary and alternative medicine among persons with diabetes mellitus: results of a national survey.Am J Public Health 2002,92(10):48\u201352.","journal-title":"Am J Public Health"},{"issue":"2","key":"880_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2337\/diacare.25.2.324","volume":"25","author":"LE Egede","year":"2002","unstructured":"Egede LE, Ye X, Zheng D, Silverstein MD: The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes.Diabetes Care 2002,25(2):324\u20139. 10.2337\/diacare.25.2.324","journal-title":"Diabetes Care"},{"key":"880_CR6","volume-title":"NBJ\u2019s Supplement Business Report 2003","author":"Nutrition Business Journal","year":"2003","unstructured":"Nutrition Business Journal: NBJ\u2019s Supplement Business Report 2003. San Diego, CA: Penton Media Inc; 2003."},{"issue":"3","key":"880_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1024\/0300-9831.74.3.178","volume":"74","author":"H Rabinovitz","year":"2004","unstructured":"Rabinovitz H, Friedensohn A, Leibovitz A, Gabay G, Rocas C, Habot B: Effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients.Int J Vitam Nutr Res 2004,74(3):178\u201382. 10.1024\/0300-9831.74.3.178","journal-title":"Int J Vitam Nutr Res"},{"key":"880_CR8","volume-title":"Chromium: Dietary supplement fact sheet","author":"National Institute of Health: Office of Dietary Supplements","year":"2013","unstructured":"National Institute of Health: Office of Dietary Supplements: Chromium: Dietary supplement fact sheet. 2013. [ONLINE] Available at: . [Accessed 09 February 15] \n                    http:\/\/ods.od.nih.gov\/factsheets\/Chromium-HealthProfessional\/"},{"issue":"7","key":"880_CR9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1021\/ar990073r","volume":"33","author":"JB Vincent","year":"2000","unstructured":"Vincent JB: Elucidating a biological role for chromium at a molecular level.Acc Chem Res 2000,33(7):503\u201310. 10.1021\/ar990073r","journal-title":"Acc Chem Res"},{"issue":"12","key":"880_CR10","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2337\/diacare.17.12.1449","volume":"17","author":"NA Lee","year":"1994","unstructured":"Lee NA, Reasner CA: Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM.Diabetes Care 1994,17(12):1449\u201352. 10.2337\/diacare.17.12.1449","journal-title":"Diabetes Care"},{"issue":"3","key":"880_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N: Meta-analysis in clinical trials.Control Clin Trials 1986,7(3):177\u201388. 10.1016\/0197-2456(86)90046-2","journal-title":"Control Clin Trials"},{"key":"880_CR12","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, Juni P, Moher D, Oxman AD, et al.: Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.BMJ 2011, 343:d5928. 10.1136\/bmj.d5928","journal-title":"BMJ"},{"issue":"7109","key":"880_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test.BMJ 1997,315(7109):629\u201334. 10.1136\/bmj.315.7109.629","journal-title":"BMJ"},{"key":"880_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/07315724.1985.10720070","volume":"4","author":"S Wallach","year":"1985","unstructured":"Wallach S: Clinical and biochemical aspects of chromium deficiency.J Am College Nutr. 1985, 4:107\u201320. 10.1080\/07315724.1985.10720070","journal-title":"J Am College Nutr"},{"issue":"3","key":"880_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jtemb.2011.03.003","volume":"25","author":"S Sharma","year":"2011","unstructured":"Sharma S, Agrawal RP, Choudhary M, Jain S, Goyal S, Agarwal V: Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes.J Trace Elem Med Biol 2011,25(3):149\u201353. doi:10.1016\/j.jtemb.2011.03.003. Epub 2011 May 12 10.1016\/j.jtemb.2011.03.003","journal-title":"J Trace Elem Med Biol"},{"issue":"11","key":"880_CR16","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.2337\/diab.46.11.1786","volume":"46","author":"RA Anderson","year":"1997","unstructured":"Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, et al.: Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.Diabetes 1997,46(11):1786\u201391. 10.2337\/diab.46.11.1786","journal-title":"Diabetes"},{"issue":"7","key":"880_CR17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/0026-0495(92)90318-5","volume":"41","author":"AS Abraham","year":"1992","unstructured":"Abraham AS, Brooks BA, Eylath U: The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes.Metabolism 1992,41(7):768\u201371. 10.1016\/0026-0495(92)90318-5","journal-title":"Metabolism"},{"issue":"9","key":"880_CR18","first-page":"831","volume":"21","author":"SM Bahijiri","year":"2000","unstructured":"Bahijiri SM, Mira SA, Mufti AM, Ajabnoor MA: The effects of inorganic chromium and brewer\u2019s yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes.Saudi Med J 2000,21(9):831\u20137.","journal-title":"Saudi Med J"},{"issue":"2","key":"880_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1385\/BTER:85:2:097","volume":"85","author":"SM Bahijri","year":"2002","unstructured":"Bahijri SM, Mufti AM: Beneficial effects of chromium in people with type 2 diabetes, and urinary chromium response to glucose load as a possible indicator of status.Biol Trace Elem Res 2002,85(2):97\u2013109. 10.1385\/BTER:85:2:097","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"880_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00394-013-0508-8","volume":"53","author":"YL Chen","year":"2014","unstructured":"Chen YL, Lin JD, Hsia TL, Mao FC, Hsu CH, Pei D: The effect of chromium on inflammatory markers, 1st and 2nd phase insulin secretion in type 2 diabetes.Eur J Nutr 2014,53(1):127\u201333. 10.1007\/s00394-013-0508-8","journal-title":"Eur J Nutr"},{"issue":"11","key":"880_CR21","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S0955-2863(02)00220-6","volume":"13","author":"D Ghosh","year":"2002","unstructured":"Ghosh D, Bhattacharya B, Mukherjee B, Manna B, Sinha M, Chowdhury J, et al.: Role of chromium supplementation in Indians with type 2 diabetes mellitus.J Nutr Biochem 2002,13(11):690\u20137. 10.1016\/S0955-2863(02)00220-6","journal-title":"J Nutr Biochem"},{"issue":"2","key":"880_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0271-5317(85)80028-2","volume":"5","author":"AE Hunt","year":"1985","unstructured":"Hunt AE, Allen KGD, Smith BA: Effect of chromium supplementation on hair chromium concentration and diabetic status.Nutr Res 1985,5(2):131\u201340. 10.1016\/S0271-5317(85)80028-2","journal-title":"Nutr Res"},{"issue":"8","key":"880_CR23","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/mnfr.201100719","volume":"56","author":"SK Jain","year":"2012","unstructured":"Jain SK, Kahlon G, Morehead L, Dhawan R, Lieblong B, Stapleton T, et al.: Effect of chromium dinicocysteinate supplementation on circulating levels of insulin, TNF-\u03b1, oxidative stress, and insulin resistance in type 2 diabetic subjects: randomized, double-blind, placebo-controlled study.Mol Nutr Food Res 2012,56(8):1333\u201341. doi:10.1002\/mnfr.201100719. Epub 2012 Jun 6 10.1002\/mnfr.201100719","journal-title":"Mol Nutr Food Res"},{"issue":"3","key":"880_CR24","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2337\/diacare.29.03.06.dc05-1453","volume":"29","author":"N Kleefstra","year":"2006","unstructured":"Kleefstra N, Houweling ST, Jansman FG, Groenier KH, Gans RO, Meyboom-de Jong B, et al.: Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial.Diabetes Care 2006,29(3):521\u20135. 10.2337\/diacare.29.03.06.dc05-1453","journal-title":"Diabetes Care"},{"issue":"2","key":"880_CR25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s12011-010-8917-5","volume":"143","author":"E Kr\u00f3l","year":"2011","unstructured":"Kr\u00f3l E, Krejpcio Z, Byks H, Bogda\u0144ski P, Pupek-Musialik D: Effects of chromium brewer\u2019s yeast supplementation on body mass, blood carbohydrates, and lipids and minerals in type 2 diabetic patients.Biol Trace Elem Res 2011,143(2):726\u201337. doi:10.1007\/s12011\u2013010\u20138917\u20135. Epub 2010 Dec 18 10.1007\/s12011-010-8917-5","journal-title":"Biol Trace Elem Res"},{"issue":"3","key":"880_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3164\/jcbn.2008064","volume":"43","author":"MH Lai","year":"2008","unstructured":"Lai MH: Antioxidant effects and insulin resistance improvement of chromium combined with vitamin C and e supplementation for type 2 diabetes mellitus.J Clin Biochem Nutr 2008,43(3):191\u20138. doi:10.3164\/jcbn.2008064. Epub 2008 Oct 31 10.3164\/jcbn.2008064","journal-title":"J Clin Biochem Nutr"},{"issue":"3","key":"880_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1385\/BTER:109:3:215","volume":"109","author":"J Racek","year":"2006","unstructured":"Racek J, Trefil L, Rajdl D, Mudrov\u00e1 V, Hunter D, Senft V: Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus.Biol Trace Elem Res 2006,109(3):215\u201330. 10.1385\/BTER:109:3:215","journal-title":"Biol Trace Elem Res"},{"issue":"4","key":"880_CR28","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ahj.2004.07.021","volume":"149","author":"M Vrtovec","year":"2005","unstructured":"Vrtovec M, Vrtovec B, Briski A, Kocijancic A, Anderson RA, Radovancevic B: Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus.Am Heart J 2005,149(4):632\u20136. 10.1016\/j.ahj.2004.07.021","journal-title":"Am Heart J"},{"issue":"5","key":"880_CR29","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.2337\/dc06-2192","volume":"30","author":"N Kleefstra","year":"2007","unstructured":"Kleefstra N, Houweling ST, Bakker SJ, Verhoeven S, Gans RO, Meyboom-de Jong B, et al.: Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a randomized, double-blind, placebo-controlled trial.Diabetes Care 2007,30(5):1092\u20136. Epub 2007 Feb 15 10.2337\/dc06-2192","journal-title":"Diabetes Care"},{"key":"880_CR30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/0003-9861(59)90479-5","volume":"85","author":"K Schwarz","year":"1959","unstructured":"Schwarz K, Mertz W: Chromium(III) and the glucose tolerance factor.Arch Biochem Biophys. 1959, 85:292\u20135. 10.1016\/0003-9861(59)90479-5","journal-title":"Arch Biochem Biophys"}],"container-title":["Nutrition Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2891-14-14.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1475-2891-14-14\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2891-14-14.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T01:02:24Z","timestamp":1491958944000},"score":1,"resource":{"primary":{"URL":"http:\/\/nutritionj.biomedcentral.com\/articles\/10.1186\/1475-2891-14-14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,13]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["880"],"URL":"https:\/\/doi.org\/10.1186\/1475-2891-14-14","relation":{},"ISSN":["1475-2891"],"issn-type":[{"value":"1475-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,13]]},"article-number":"14"}}